The Race for a Vaccine

For years, a debate has been simmering in Silicon Valley over the right way to build artificial intelligence. Should it be open and free for anyone to use, or should we tightly control how it’s made and who can access it? Mike Isaac, who covers technology for The New York Times, ...  Show more

This summer, wildfires have been raging across Europe. France and Spain have been hit particularly badly, with hundreds of thousands of acres incinerated and entire communities devastated. Chico Harlan, the global climate correspondent for The New York Times, and Mark Landler, th ...  Show more

Researchers around the world are racing to develop a vaccine against Covid-19, with more than 170 candidate vaccines now in development. Most vaccines take years of testing and additional time to produce at scale, but scientists are hoping to develop a coronavirus vaccine at reco ...  Show more

On the same day the COVID-19 death toll surpassed 300,000 in the United States, the first vaccines are being administered, finally giving millions of Americans hope for a better future and a return to normalcy. We explore how officials expect to deliver a safe and effective vacci ...  Show more

A vaccine for Covid-19 could come faster than previous vaccines, but it could still be a year or more before one is widely available. CNN's Chief Medical Correspondent Dr. Sanjay Gupta talks to a clinical trial participant and explains why this vaccine search is breaking barriers ...  Show more

The hunt for a coronavirus vaccine is central to global efforts to restart economies. The FT’s US coronavirus correspondent, David Crow, explains how nationalism could slow the fight against the pandemic. Plus, some companies are presenting a new customised metric they are cal ...